Sep 02, 2026
By Transpire Insight
Description
According to a research report published by Transpire Insight, the hypodermic syringes and needles market size is projected to grow from USD 10.6 billion in 2026 to USD 17.5 billion by 2035, at a CAGR of 9.46% during the forecast period 2026-2035. The growing prevalence of chronic diseases, growing immunization campaigns around the world, rapid adoption of self-administered medications such as GLP-1 agonists, and stringent regulations for safety-engineered devices to reduce healthcare worker needlestick injuries are the key drivers of the hypodermic syringes and needles market.
Introduction
The hypodermic syringes and needles market is a pivotal part of healthcare systems that plays a substantial role in blood collection, drug injection, and vaccination drives. This market of billions of dollars is quickly evolving towards a change in technology from traditional disposable syringes to safety-engineered, auto-disable, and prefilled syringe platforms. The international health requirements are stringent, and the demand for in-home treatment of biologic and insulin continues to grow, fueling long-term growth in the developed clinical environment and emerging healthcare economies around the world.
Recent Development News
Stay Ahead of Emerging Opportunities with Expert Market Insights by Transpire Insight
Transpire Insight provides comprehensive, data-driven market intelligence to support smarter business decisions. Our research is rooted in comprehensive analysis, authoritative predictions, and industry expertise, enabling organizations to make informed decisions in rapidly evolving markets. In-depth analysis of market segmentation, competitive positioning, regional trends, and emerging investment opportunities in high-growth areas. We blend accuracy with actionable intelligence, empowering companies to uncover new avenues for growth, bolster strategic decision-making, and stay ahead in a dynamic market.
Hypodermic Syringes and Needles Market Size & Statistics
Regional Growth and Demand Analysis by Transpire Insight
North America's dominance rests on its mature injectable-drug ecosystem and dense hospital infrastructure, with manufacturers actively reinforcing local capacity to defend that lead. BD recently expanded its manufacturing footprint for advanced prefillable syringes to improve the biologics injection experience, while a domestic acquisition brought InjectEZ LLC's copolymer prefillable syringe line under a larger US supplier seeking to meet multi-year purchase commitments from pharmaceutical customers. High insurance penetration, OSHA-driven safety mandates, and rapid uptake of safety-engineered sharps keep replacement cycles frequent, and the region's concentration of major players such as BD, Terumo, and Cardinal Health further cements its position as the anchor market for premium, safety-first devices.
Asia Pacific's rapid ascent is being driven less by replacement demand and more by first-time infrastructure build-out. Terumo introduced an injection filter needle carrying a fine polyamide mesh filter under its INFINO development program, reflecting the region's growing push into higher-value, specialized needle technology rather than commodity products. Meanwhile, India and Indonesia are leaning on Gavi and UNICEF funding to roll out auto-disable devices at scale, and China has tightened import controls on substandard syringes while aligning with WHO guidance, accelerating a shift toward certified, quality-assured supply. Growing middle-class populations and rising diabetes and cardiovascular disease incidence continue to widen the region's patient base.
Top 15 Trends in the Hypodermic Syringes and Needles Market
Rising Adoption of Safety-Engineered Needles
Hospitals are rapidly replacing conventional needles with safety-engineered versions featuring retractable or shielded mechanisms, driven by occupational safety mandates reducing needlestick injuries among healthcare workers.
Growth of Prefillable Syringe Formats
Manufacturers are scaling prefillable syringe production to meet rising biologics demand, since ready-to-use formats cut dosing errors, contamination risk, and drug preparation time for clinicians.
Smart and connected syringe technology adoption
Connected syringe technologies with dose-tracking sensors and app integration are gaining traction, helping patients and caregivers monitor injection adherence remotely, especially for chronic disease management.
Needle-Stick Injury Prevention Regulations Tightening Globally
Stringent occupational safety regulations, including OSHA-style mandates, now require safety-engineered sharps across many countries, pushing hospitals to retire conventional needles for improved worker safety overall.
Increased Vaccination and Immunization Program Funding
Expanding immunization programs backed by Gavi and UNICEF funding are boosting bulk syringe procurement across low- and middle-income countries, sustaining steady demand for auto-disable devices.
Auto-Disable Syringe Rollout in Emerging Markets
India and Indonesia are scaling auto-disable syringe adoption through donor-funded immunization drives, reducing reuse risks and reinforcing WHO-recommended injection safety practices across public health systems.
Top 25 Companies Leading the Hypodermic Syringes and Needles Market
1. Becton, Dickinson and Company (BD)
medical technology leader pioneering safety-engineered injection devices and diagnostic solutions.
Founded: 1897 | HQ: Franklin Lakes, New Jersey, USA.
Why It Ranks: Unmatched market share driven by industry-standard safety syringes and extensive manufacturing capabilities.
Regional Dominance: Commands a dominant presence across North America, Europe, and major Asia-Pacific healthcare markets.
Product Line: BD Plastipak syringes, BD Eclipse safety needles, and BD Hypopak prefillable systems.
2. B. Braun Melsungen AG
German healthcare titan manufacturing precision medical equipment, infusion products, and surgical instruments.
Founded: 1839 | HQ: Melsungen, Germany.
Why It Ranks: Comprehensive injection portfolio backed by sustainable production and high European clinical trust.
Regional Dominance: Strongly dominates Western Europe while aggressively expanding across Asia-Pacific and Latin America.
Product Line: Injekt single-use syringes, Sterican hypodermic needles, and Omnifix fine dosage syringes.
3. Terumo Corporation
Japanese medical pioneer excelling in vascular access, blood management, and injection technologies.
Founded: 1921 | HQ: Tokyo, Japan.
Why It Ranks: Recognized globally for ultra-thin needle engineering and innovative passive safety mechanism integration.
Regional Dominance: Dominates Japan and East Asia with deep market penetration across European facilities.
Product Line: Nanopass fine needles, SurGuard safety hypodermic needles, and K-Pack dental needles.
4. Nipro Corporation
Leading manufacturer of renal, pharmaceutical packaging, and high-precision hypodermic medical supplies.
Founded: 1954 | HQ: Osaka, Japan.
Why It Ranks: High-volume manufacturing excellence offering cost-effective and dependable hypodermic injection and needle lines.
Regional Dominance: Maintains massive market control in Asia while expanding automated assembly hubs globally.
Product Line: Nipro disposable hypodermic syringes, SafeTouch safety needles, and pharmacy compounding accessories.
5. Cardinal Health, Inc.
Multinational healthcare services giant manufacturing and distributing essential medical products worldwide.
Founded: 1971 | HQ: Dublin, Ohio, USA.
Why It Ranks: Massive distribution networks supply hospitals with reliable, high-volume, standardized hypodermic injection consumables.
Regional Dominance: Holds an overwhelming footprint in North America with growing institutional reach across South America.
Product Line: Monoject hypodermic needles, Monoject safety syringes, and enteral medication delivery devices.
6. Medtronic plc
medical device innovator delivering targeted drug delivery, surgical, and therapeutic hardware solutions.
Founded: 1949 | HQ: Dublin, Ireland.
Why It Ranks: High clinical trust and strategic cross-selling across hospital surgical networks drive adoption.
Regional Dominance: Strong footprint with leading market shares in North America and Western Europe.
Product Line: Specialist specialty needles, vascular access needles, and prefilled injection accessories for therapies.
7. ICU Medical, Inc.
Specialist infusion and vascular access provider enhancing patient safety with specialized syringe devices.
Founded: 1984 | HQ: San Clemente, California, USA.
Why It Ranks: Strengthened position following strategic acquisitions to offer complete safety-engineered needle and tubing ranges.
Regional Dominance: Maintains prominent clinical presence in North America, Latin America, and European health systems.
Product Line: Jelco hypodermic needles, Portex specialized safety needles, and dedicated syringe system components.
8. Gerresheimer AG
Key partner to the pharma industry producing specialized primary glass and plastic delivery systems.
Founded: 1864 | HQ: Düsseldorf, Germany.
Why It Ranks: leadership in primary packaging for prefillable syringes and advanced drug containment solutions.
Regional Dominance: Holds commanding market positions across Europe and expanding manufacturing operations in North America.
Product Line: Gx GX-Ready prefillable glass syringes, integrated safety shields, and custom hypodermic barrels.
9. SCHOTT AG
International technology group specializing in high-grade pharmaceutical glass and drug delivery containers.
Founded: 1884 | HQ: Mainz, Germany.
Why It Ranks: Renowned expertise in durable glass formulations critical for modern high-precision prefilled syringes.
Regional Dominance: Deeply embedded across European pharmaceutical manufacturing hubs with strong distribution networks.
Product Line: SCHOTT TOPPAC polymer syringes, syriQ prefillable glass syringes, and specialized needle accessories.
10. Retractable Technologies, Inc.
Specialized innovator focused on safety-engineered needle products preventing accidental needlestick injuries and reuse.
Founded: 1994 | HQ: Little Elm, Texas, USA.
Why It Ranks: Patented automated needle retraction technology sets high industry standards for healthcare worker safety.
Regional Dominance: Strong footprint in North American government procurement and growing adoption in international markets.
Product Line: VanishPoint retractable syringes, VanishPoint blood collection needles, and Patient Safe safety needles.
Conclusion
Continuous vaccination campaigns, the necessity for injections for chronic diseases, and stringent safety measures for workers make the hypodermic syringes and needles market an unreplaceable component of the healthcare sector globally. The industry is continually improving in terms of safety options, prefilled convenience, and sustainable manufacturing. With regulatory expectations for safer and more environmentally friendly delivery methods, leading manufacturers will be ideal candidates for future technological and clinical advances.
Send us a brief description of your challenge and we'll get back to you within 24 hours.
inquiry@transpireinsight.com
APAC:+91 7666513636
Address
